Intra-articular Hyaluronan Injections for Osteoarthritis
Summary
Durolane and Euflexxa may be considered medically necessary for painful osteoarthritis of the knee in patients who have insufficient pain relief from conservative nonpharmacologic therapy and simple analgesics. Repeated courses of these two products may be considered medically necessary only when the prior course gave significant pain relief and at least six months have passed since the prior course in the affected knee, and intra-articular hyaluronan injections into joints other than the knee are considered investigational. The other listed hyaluronan products are not covered on any BCBSMS Formulary.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.